Stay updated with breaking news from Label Extension. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Based on topline results from the Phase 3 PHOENIX trial of AMX0035 in ALS, Amylyx has started a process with the FDA and Health Canada of voluntarily discontinuing the marketing authorizations for...
Upcoming data presentations underscore the potential for FILSPARI to become a foundational treatment for IgAN and Travere’s leadership and commitment to innovation in rare kidney disease SAN DIEGO,...
Company Poised for Pivotal Trial Results and FDA Discussions in 2024
Long-term data show clinical remission and endoscopic response rates are maintained and even improve over time in patients with moderate to severe Crohn's disease, according to a new study.
Montrouge, France, February 20 2024 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress DBV Technologies , a clinical-stage biopharmaceutical company focused on treatments for food...